Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm acrosome membrane-associated protein 3 (SPACA3, also known as SLLP1/SPRASA) is a sperm-specific, lysozyme-like protein localized to the acrosomal matrix of human sperm. Despite strong structural similarity to conventional lysozymes, it lacks catalytic bacteriolytic activity and instead is implicated in the adhesion and binding to egg extracellular matrix carbohydrates (notably N-acetylglucosamine), promoting sperm–oocyte interaction during fertilization. SPACA3 is expressed almost exclusively in testis and sperm, with aberrant expression observed in some cancers, qualifying it as a cancer-testis antigen. Variant forms and immunoreactivity have also been associated with male and female infertility, with additional roles in ovarian follicle and corpus luteum biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm acrosome membrane-associated protein 3 (SPACA3).